May 15, 2024 04:00PM
Apr 16, 2024 08:00AM
Feb 14, 2024 05:50AM
Feb 13, 2024 07:04PM
Nov 14, 2023 04:05PM
Sep 6, 2023 08:02AM
Sep 6, 2023 08:00AM VBI Vaccines Partner Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination With PEG-IFNα for the Treatment of Chronic Hepatitis B
Sep 6, 2023 06:45AM
Aug 14, 2023 08:00AM
Jul 24, 2023 08:00AM
Jul 19, 2023 08:00AM
Jul 6, 2023 09:00AM
Jul 6, 2023 09:00AM
Jul 5, 2023 07:24PM Brii Biosciences Broadens its Leadership in Hepatitis B with a Portfolio Now Addressing Disease's Burdens from Prevention to Cure
Jul 5, 2023 04:13PM
Jul 5, 2023 04:12PM
Jul 5, 2023 04:02PM
Jul 5, 2023 04:01PM
Jun 25, 2023 08:00AM
Jun 15, 2023 08:00AM
Jun 7, 2023 08:00AM  VBI Vaccines Announces Poster Presentation at EASL 2023
May 15, 2023 08:00AM
Apr 25, 2023 08:03AM
Apr 25, 2023 08:00AM
Apr 4, 2023 08:02AM
Apr 4, 2023 08:00AM
Mar 24, 2023 01:18AM
Mar 13, 2023 08:00AM VBI Vaccines Reports Full Year 2022 Financial Results
Feb 23, 2023 08:00AM
Feb 15, 2023 08:03AM
Feb 15, 2023 08:00AM
Dec 8, 2022 08:00AM
Nov 10, 2022 08:00AM
Sep 21, 2022 08:00AM
Sep 15, 2022 08:30AM VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures
Sep 8, 2022 01:00AM
Sep 8, 2022 01:00AM
Aug 8, 2022 08:00AM
Jul 12, 2022 08:00AM
Jul 12, 2022 08:00AM
Jun 28, 2022 08:01AM
Jun 28, 2022 08:00AM VBI Vaccines Announces New Long-Term Follow-Up Clinical Data for its 3-Antigen Adult Hepatitis B Vaccine Presented at EASL 2022
Jun 1, 2022 08:01AM
Jun 1, 2022 08:00AM
May 26, 2022 08:00AM
May 19, 2022 08:00AM
May 9, 2022 08:00AM
May 2, 2022 08:06AM
May 2, 2022 08:00AM VBI Vaccines Announces European Commission Marketing Authorisation for PreHevbri™, a 3-Antigen Adult Hepatitis B Vaccine
Mar 29, 2022 08:00AM

64,524 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All